Benchmark Reiterates Speculative Buy on Modular Medical, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
Benchmark analyst Bruce Jackson has reiterated a Speculative Buy rating on Modular Medical (NASDAQ:MODD) and maintained a $5 price target.
June 30, 2023 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst has reiterated a Speculative Buy rating on Modular Medical and maintained a $5 price target.
The reiteration of a Speculative Buy rating by a Benchmark analyst and the maintenance of a $5 price target could potentially boost investor confidence in the stock, leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100